NCT05505968

Brief Summary

For a few years, publications have been published concerning the use of virtual reality headsets in the field of medicine and particularly in various specialities. It has been evaluated in different studies on pain and anxiety in various medical situations. A study has shown a correlation between a decrease in pain in a clinical way during a painful stimulation and a decrease in certain areas of the brain. In this context, the use of the virtual reality headset could then be used in medical interventions that may be painful for the patient. The lumbar radicular pain is a common disease in the world. The epidural injection is one of the treatment of this pathology. He may be performed to reduce the pain but sometimes this act is painful. Most of the time this procedure is performed without premedication. To the knowledge of the investigators, there are currently no studies on the assessment of pain under a virtual reality headset during the performance of an epidural injection in rheumatology. The aim of the study is to demonstrate that the Virtual Reality Headset can reduce the pain and the anxiety during an epidural injection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 8, 2022

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 16, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 18, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2023

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2024

Completed
Last Updated

January 21, 2026

Status Verified

January 1, 2024

Enrollment Period

7 months

First QC Date

August 16, 2022

Last Update Submit

January 19, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • State-Trait Anxiety Inventory

    State-Trait Anxiety Inventory STAI-B (trait anxiety), STAI-A (state anxiety)

    Day 1

  • State-Trait Anxiety Inventory

    STAI-B (trait anxiety), STAI-A (state anxiety)

    Day 3

Study Arms (2)

virtual reality - Day1

EXPERIMENTAL

Use of the virtual reality headset during the first epidural infiltration (Day 1). The second infiltration (Day 3) will be performed without the virtual reality headset.

Other: Virtual Reality Headset

virtual reality - Day3

EXPERIMENTAL

First epidural infiltration without the virtual reality headset (day 1). The second infiltration will be performed with the virtual reality headset (Day 3).

Other: Virtual Reality Headset

Interventions

Virtual Reality Headset of the society Healthy Mind and is a CE Class 1 medical device. This virtual reality headset is a Pico G2 4K and corresponds to the model A7510 and is connected to a Bose Sound Link 2 AE headset.

Also known as: Medical device
virtual reality - Day1virtual reality - Day3

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 18-90 years,
  • Diagnosed with lomboradiculalgia requiring two epidural injection through the sacrococcygeal hiatus,
  • Hospitalized in the Rheumatology Department of the University Hospital of Reims,
  • Speak French language.
  • Affiliated or beneficiary of a social security scheme
  • Having given their written agreement to participate in the study (signature of the consent form)

You may not qualify if:

  • Profound or total deafness,
  • Visually impaired,
  • Presence of contraindication to injection,
  • Inability to answer the questionnaire due to severe cognitive impairment,
  • Injection with and without virtual reality headset not performed by the same person,
  • Vestibular pathologies,
  • Epilepsy,
  • Claustrophobia,
  • Use of nitrous oxide for injection.
  • Premedication for infiltration (analgesic, anxiolytic)
  • Patients under guardianship, curatorship, safeguard of justice
  • Pregnant women
  • Psychotic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Reims

Reims, 51092, France

Location

Related Publications (1)

  • Javelot M, Chopin C, Bolko L, Hittinger A, Geoffroy M, Charlot I, Adeline F, Coutureau C, Duvivier A, Salmon JH. Effect of Virtual Reality on Pain and Anxiety During Epidural Steroid Injection in Patients with Lumbar Radicular Pain: An Open-Label Randomized Trial. Healthcare (Basel). 2025 Sep 22;13(18):2376. doi: 10.3390/healthcare13182376.

MeSH Terms

Interventions

Equipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2022

First Posted

August 18, 2022

Study Start

August 8, 2022

Primary Completion

February 22, 2023

Study Completion

January 12, 2024

Last Updated

January 21, 2026

Record last verified: 2024-01

Locations